Top Markets
Coin of the day
AIxCrypto Holdings, Inc. AIxCrypto Holdings, Inc.

AIxCrypto Holdings, Inc.

AIXC
Classement en actions #27458
AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company... AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quadruplexes (G4)-selective transcription inhibitor currently progressing through Phase I clinical trials for pancreatic cancer and a range of other solid tumors. The firm is also advancing Pan-RAS, a preclinical-stage program targeting advanced solid tumors. Founded in 1996 and headquartered in Carlsbad, California, the company rebranded from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc. in November 2025.
Prix de l'action
$1.62
Dernière synchronisation: 2026-08-19
Capitalisation boursière
$32.77M
Changement (1 jour)
22.67%
Changement (1 an)
-13.87%
Pays
US
Échange AIxCrypto Holdings, Inc. (AIXC)

Catégorie

Historique du prix de l'action pour AIxCrypto Holdings, Inc. (AIXC)
Prix de clôture le plus élevé : $0.90 le 2026-08-01

Prix de clôture le plus bas : $589.38K le 2015-06-01
Historique du prix de l'action de AIxCrypto Holdings, Inc. de 2015 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -22.79%
2025 -39.97%
2024 -86.58%
2023 -55.55%
2022 -87.61%
2021 -67.06%
2020 -20.10%
2019 -75.33%
2018 -77.35%
2017 -88.49%
2016 37.25%
2015 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$61.63 67.11%
US
$51.85 75.00%
SE
$197.14 46.35%
FR
$119.62 69.92%
US
$62.93 2.96%
IT